We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+7.72%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.33B
AUM Growth
+$165M
(+14%)
Cap. Flow
+$81.5M
Cap. Flow
% of AUM
6.12%
Top 10 Holdings %
Top 10 Hldgs %
31.77%
Holding
2,605
New
162
Increased
932
Reduced
550
Closed
151
Avg Time Held Equity + Options
2.1
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1.8
years
Avg Time Held Equity only
2.1
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$19.3M |
| 2 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$13.4M |
| 3 |
iShares MSCI USA Size Factor ETF
SIZE
|
+$10.8M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$10.4M |
| 5 |
Uber
UBER
|
+$4.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Onto Innovation
ONTO
|
+$6.7M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$4.58M |
| 3 |
Microsoft
MSFT
|
+$4.38M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$2.92M |
| 5 |
iShares MBS ETF
MBB
|
+$1.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.04% |
| 2 | Technology | 11.88% |
| 3 | Financials | 6% |
| 4 | Healthcare | 5.64% |
| 5 | Communication Services | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
DELISTED
Esperion Therapeutics
ESPR
| $1.06M | 0.08% |
17,710
+10,000
| +130% | +$450K |
2019 Q3
1 quarter
|
|
177
Everpure Inc
P
$44.4B
| $1.05M | 0.08% |
61,475
-11,000
| -15% | -$195K |
2016 Q4
12 quarters
|
|
178
Medtronic
MDT
$122B
| $1.05M | 0.08% |
9,230
+331
| +4% | +$36.3K |
2016 Q4
12 quarters
|
|
179
Berkshire Hathaway Class A
BRK.A
$1.14T
| $1.02M | 0.08% |
3
+2
| +200% | +$651K |
2016 Q4
12 quarters
|
|
180
Bain Capital Specialty
BCSF
$680M
| $1.02M | 0.08% |
52,520
-11,988
| -19% | -$225K |
2019 Q1
3 quarters
|
|
181
TJX Companies
TJX
$161B
| $1M | 0.08% |
16,394
-6,776
| -29% | -$401K |
2016 Q4
12 quarters
|
|
182
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.6B
| $995K | 0.07% |
20,195
+4,877
| +32% | +$240K |
2016 Q4
12 quarters
|
|
183
State Street SPDR S&P Biotech ETF
XBI
$9.78B
| $987K | 0.07% |
10,380
+198
| +2% | +$17.1K |
2016 Q4
12 quarters
|
|
184
Alerian MLP ETF
AMLP
$12.6B
| $982K | 0.07% |
23,105
-4,124
| -15% | -$173K |
2016 Q4
12 quarters
|
|
185
iShares ESG Aware MSCI USA ETF
ESGU
$17.9B
| $967K | 0.07% |
13,566
+13,505
| +22,139% | +$919K |
2019 Q3
1 quarter
|
|
186
Qualcomm
QCOM
$185B
| $966K | 0.07% |
10,950
+499
| +5% | +$41.7K |
2016 Q4
12 quarters
|
|
187
Okta
OKTA
$36.2B
| $964K | 0.07% |
8,354
-989
| -11% | -$114K |
2018 Q1
7 quarters
|
|
188
Martin Marietta Materials
MLM
$34.1B
| $950K | 0.07% |
3,396
+10
| +0.3% | +$2.67K |
2016 Q4
12 quarters
|
|
189
Chubb
CB
$138B
| $946K | 0.07% |
6,077
-207
| -3% | -$31.7K |
2016 Q4
12 quarters
|
|
190
Blackstone
BX
$84.6B
| $932K | 0.07% |
16,664
+525
| +3% | +$27.2K |
2016 Q4
12 quarters
|
|
191
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.7B
| $931K | 0.07% |
14,948
-2,258
| -13% | -$136K |
2016 Q4
12 quarters
|
|
192
Schwab Fundamental International Large Company Index ETF
FNDF
$25.4B
| $926K | 0.07% |
32,025
+376
| +1% | +$10.7K |
2018 Q1
7 quarters
|
|
193
Limoneira
LMNR
$217M
| $924K | 0.07% |
48,035
| – | – |
2018 Q1
7 quarters
|
|
194
Northrop Grumman
NOC
$71.9B
| $924K | 0.07% |
2,685
+93
| +4% | +$32.7K |
2016 Q4
12 quarters
|
|
195
Elevance Health
ELV
$93.3B
| $905K | 0.07% |
2,995
-72
| -2% | -$19.8K |
2016 Q4
12 quarters
|
|
196
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22B
| $899K | 0.07% |
14,332
+1,486
| +12% | +$90.4K |
2016 Q4
12 quarters
|
|
197
SPDR Gold Trust
GLD
$141B
| $896K | 0.07% |
6,267
-460
| -7% | -$64.3K |
2016 Q4
12 quarters
|
|
198
Schwab US Aggregate Bond ETF
SCHZ
$10.7B
| $895K | 0.07% |
33,486
-17,130
| -34% | -$459K |
2016 Q4
12 quarters
|
|
199
Arcus Biosciences
RCUS
$2.87B
| $877K | 0.07% |
86,855
+800
| +0.9% | +$6.73K |
2019 Q2
2 quarters
|
|
200
IBM
IBM
$216B
| $871K | 0.07% |
6,800
-573
| -8% | -$74.5K |
2016 Q4
12 quarters
|
|
Similar funds
Parallel Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Parallel Advisors held 2,605 positions worth $1.33B, up 14% from $1.17B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parallel Advisors deployed $81.5M of net new capital in Q4 2019, opening 162 new positions and adding to 932 existing holdings. Its largest new stake was iShares MSCI USA Size Factor ETF: 115,543 shares worth $11.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 57% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $4.58M trimmed.
- Parallel Advisors's largest Q4 2019 buy was iShares MSCI USA Size Factor ETF: 115,543 shares worth $11.3M.
- Parallel Advisors added most to iShares Core S&P Total US Stock Market ETF in Q4 2019, an estimated $19.3M increase.
- Parallel Advisors's biggest Q4 2019 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $4.58M.
- Parallel Advisors fully exited Onto Innovation in Q4 2019, selling an estimated $6.7M.
- Parallel Advisors's ten largest holdings make up 32% of its $1.33B portfolio in Q4 2019.
- Parallel Advisors opened 162 new positions and closed 151 in Q4 2019.
- Parallel Advisors's portfolio value rose 14% quarter-over-quarter to $1.33B.
Based on Parallel Advisors's 13F filing for Q4 2019, filed 30 Jan 2020.